Roivant Sciences Ltd. (ROIV)
29.06
+0.56
(+1.98%)
USD |
NASDAQ |
Jun 09, 16:00
29.06
0.00 (0.00%)
After-Hours: 20:00
Roivant Sciences EPS Diluted (Quarterly) : 0.373 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Centessa Pharmaceuticals Plc | -0.5152 |
| Aptorum Group Ltd. | -0.0378 |
| Bicycle Therapeutics Plc | -0.8714 |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Kiniksa Pharmaceuticals International Plc | 0.2741 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 355.74M |
| Revenue (Quarterly) | 2.52M |
| Total Expenses (Quarterly) | -300.47M |
| Enterprise Value | 17.10B |
| Gross Profit Margin (Quarterly) | 61.98% |
| Earnings Yield | -1.73% |
| Normalized Earnings Yield | -4.235 |